What was the primary objective of the TRANSFORM study?
To investigate the efficacy and safety of liso-cel in patients with newly diagnosed large B-cell lymphoma
To compare the efficacy and safety of liso-cel in patients with high-risk, second-line large B-cell lymphoma
To investigate the efficacy and safety of liso-cel in patients with mantle cell lymphoma